TOVX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Theriva Biologics Inc (TOVX) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows weak technical indicators, no recent positive news or catalysts, and lacks strong trading signals from Intellectia Proprietary Trading Signals. Additionally, the price trend and analyst targets suggest limited upside potential in the near term.
The MACD is negative and expanding, indicating bearish momentum. RSI is at 33.888, which is neutral but leaning towards oversold territory. The stock is trading below key pivot levels, with support at $0.226 and resistance at $0.312. Converging moving averages indicate no clear trend.
Maxim upgraded the stock to Buy from Hold with a $1 price target, citing potential progress in VCN-01 for metastatic pancreatic cancer.
The stock has shown a consistent downtrend with a -7.00% regular market change and a pre-market decline of -2.59%. Technical indicators suggest bearish momentum, and there is no recent news or significant insider or hedge fund activity to support a positive outlook.
No financial data available for the latest quarter.
Maxim upgraded the stock to Buy from Hold with a $1 price target, reflecting optimism about the company's pipeline progress. However, this is the only recent analyst action, and the stock remains speculative.
